NF-κB epigenetic attractor landscape drives breast cancer heterogeneity
Authors:
Open Access
- 24 November 2025
- journal article
- research article
- Published by Springer Nature in npj Systems Biology and Applications
- Vol. 11 (1) , 135
Abstract
Heterogeneity in breast cancer (BC) subtypes within a tumor contributes to therapy resistance and cancer recurrence. Subtype heterogeneity in tumors arises through a combination of stochastic genetic/epigenetic changes, phenotypic plasticity, and microenvironment-driven selection as the tumor evolves over time. Here, we sought to characterize how NF-κB epigenetic variability contributes to the progression of the HER2 + BC subtype. Initially, we used RNA to determine the expression levels of NF-κB, TWIST1, SIP1, and SLUG in two breast cancer (BC) cell lines, HCC-1954 and MDA-MB-231, classified as HER2 + and triple-negative breast cancer (TNBC) subtypes, respectively. Then, we built and calibrated a gene regulatory network (GRN) model that reproduces the transcriptional interactions between these genes. The model epigenetic landscape exhibits two attractor basins that reproduces the observed expression profiles of both HER2 + and TNBC subtypes, separated by an unstable stationary state. For validation, we used DHMEQ-treated cells, along with published patient data and in vitro results. Stochastic fluctuations in the NF-κB levels induce spontaneous irreversible transition from HER2 + to TNBC attractor basins at different times, contributing to subtype heterogeneity. The unstable state mediates this transition by providing a slow route between subtypes in the phase space that is susceptible to dynamic fluctuations. Mutations or drugs that change the availability of NF-κB alters the size of the subtype basins, changing the transition probabilities. Together, our findings enhance the established attractor landscape formulation and deepen understanding of BC heterogeneity, leading to more precise classification, prognosis, and targeted strategies for BC progression.Keywords
All Related Versions
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (200176/2022-6)
This publication has 45 references indexed in Scilit:
- Six distinct NFκB signaling codons convey discrete information to distinguish stimuli and enable appropriate macrophage responsesImmunity, 2021
- The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseasesGenes & Diseases, 2021
- A Monte Carlo method for in silico modeling and visualization of Waddington’s epigenetic landscape with intermediate detailsBioSystems, 2020
- Hybrid modeling frameworks of tumor development and treatmentWIREs Mechanisms of Disease, 2019
- Foundations of Chemical Reaction Network Theory2019
- NF-κB in pancreatic cancer: Its key role in chemoresistanceCancer Letters, 2018
- The positive is inside the negative: HER2-negative tumors can express the HER2 intracellular domain and present a HER2-positive phenotypeCancer Letters, 2015
- Smad interacting protein 1 (SIP1) is associated with peritoneal carcinomatosis in intestinal type gastric cancerClinical & Experimental Metastasis, 2012
- Cancer attractors: A systems view of tumors from a gene network dynamics and developmental perspectiveSeminars in Cell & Developmental Biology, 2009
- Differentiation of malignant to benign cellsJournal of Theoretical Biology, 1971